On September 1, Oregon officially reinstalled criminal penalties for drug possession under House Bill 4002, ending a nearly four-year experiment with drug decriminalization. This shift, which ironically comes just a day after International Overdose Awareness Day, is drawing sharp criticism from advocacy groups, who argue that the new law will exacerbate the very issues it was meant to solve.
Rollback Of Ballot Measure 110: A Pivot From Public Health To Punishment
House Bill 4002, signed by Governor Tina Kotek (D) on April 1, reintroduces misdemeanor charges for possessing small amounts of drugs, such as fentanyl and methamphetamine, effectively rolling back the key provisions of ballot Measure 110, which Oregon voters passed in 2020. Measure 110 sought to address problematic drug use as a public health issue, redirecting individuals towards treatment rather than incarceration. However, criticisms of the measure's implementation and its perceived failure to reduce overdose deaths led lawmakers to pivot back to a more punitive approach.
- Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you’re serious about the business, you can’t afford to miss out.
Oregon’s Deflection Programs And Its Patchy Implementation
The new law also introduces “deflection programs,” intended to steer individuals into treatment rather than jail. Yet, these programs are optional and vary widely in their application across the state. According to the Drug Policy Alliance (DPA), only 28 of Oregon's 36 counties have sought state funding to implement such programs, and most are not yet operational. This patchwork approach has raised concerns that many individuals will be left without meaningful access to treatment, instead cycling through the criminal justice system.
Advocates Condemn Revival Of Failed Policies
Advocacy groups argue that H.B. 4002 is a step backward, reviving the failed drug policies that have disproportionately affected communities of color. “Make no mistake, H.B. 4002 is taken from the same drug war playbook that has failed us for decades: cycle people in and out of jails, spend more resources on law enforcement that could go towards services people need, and saddle people – especially people of color – with criminal records that act as barriers to housing, employment, benefits, and education for the rest of their lives," said Lindsay LaSalle, managing director of policy at the DPA. Critics also highlight the state's ongoing shortage of public defenders, which could result in many drug possession cases being dismissed without connecting individuals to any support services.
Oregon's Treatment Infrastructure Lags Behind Needs
Despite the reinstatement of criminal penalties, Oregon's treatment infrastructure remains underdeveloped, with significant gaps in services such as residential treatment and withdrawal management. For example, a deflection center was planned in Multnomah County, but its opening has been delayed, as detailed by the OPB.
Similarly, most of Oregon's counties are either unprepared or unwilling to implement comprehensive deflection programs by the law's effective date. Meanwhile, police will arrest and possibly detain drug users until a deflection team can intervene.
Just after the day meant to honor those lost to overdose, Oregon's decision to recriminalize drug possession could mean going back into the controversial era that many hoped had ended. Advocates continue to call for investment in public health solutions, arguing that support services, not punishment, is the key to saving lives.
Read Next:
Featured image was generated with AI tools.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.